摘要
目的:观察依达拉奉联合奥扎格雷钠治疗进展性脑梗死的临床疗效。方法:72例进展性脑梗死随机分为治疗组和对照组各36例,对照组给予常规治疗,治疗组在常规治疗基础上应用依达拉奉30 mg加生理盐水100 ml静滴,2次/d;奥扎格雷钠80 mg加生理盐水250 ml静滴,2次/d,疗程均为2周,观察2组临床疗效。结果:治疗组总有效率(91.7%)高于对照组总有效率(69.4%),差异有统计学意义(P<0.05)。结论:依达拉奉联合奥扎格雷钠治疗进展性脑梗死有较好疗效。
Objective： To observe the curative effects of Edaravone combined with Sodium ozagrel on treating progressive cerebral infarction（PCI）. Methods： 72 patients with PCI were randomly divided into two groups.Control group（36 patients） was treated with conventional therapy,Treatment group（36 patients） was treated with Edaravone 30 mg iv dirp bid for 14 days,and Sodium ozagrel 80 mg iv drip bid for 14 days.Therapeutic effect was evaluated by clinical efficacy. Results： The total effective rate（91.7%） of the treatment group was obviously higher than that of the control group（69.4%）（P0.05）. Conclusion： Treatment of Edaravone combined with Sodium ozagrel can safely improve the symptom of PCI patients.
出处
《河南医学研究》
CAS
2011年第4期438-439,442,共3页
Henan Medical Research
关键词
依达拉奉
奥扎格雷钠
进展性脑梗死
edaravone
sodium ozagrel
progressive cerebral infarction
